These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23534930)

  • 1. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
    Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
    Carballeira NM; Cartagena M; Sanabria D; Tasdemir D; Prada CF; Reguera RM; Balaña-Fouce R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6185-9. PubMed ID: 22932312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
    Ray S; Hazra B; Mittra B; Das A; Majumder HK
    Mol Pharmacol; 1998 Dec; 54(6):994-9. PubMed ID: 9855627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel betulin derivatives as antileishmanial agents with mode of action targeting type IB DNA topoisomerase.
    Chowdhury S; Mukherjee T; Sengupta S; Chowdhury SR; Mukhopadhyay S; Majumder HK
    Mol Pharmacol; 2011 Oct; 80(4):694-703. PubMed ID: 21750153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
    Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.
    Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; González M; Rubiales G; Palacios F
    Eur J Med Chem; 2018 May; 152():137-147. PubMed ID: 29704722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.
    Carballeira NM; Montano N; Alvarez-Velilla R; Prada CF; Reguera RM; Balaña-Fouce R
    Mar Drugs; 2013 Sep; 11(10):3661-75. PubMed ID: 24084785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new bisbenzylisoquinoline alkaloid isolated from Thalictrum foliolosum, as a potent inhibitor of DNA topoisomerase IB of Leishmania donovani.
    Kumar A; Chowdhury SR; Sarkar T; Chakrabarti T; Majumder HK; Jha T; Mukhopadhyay S
    Fitoterapia; 2016 Mar; 109():25-30. PubMed ID: 26625837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis-like death in Leishmania donovani promastigotes induced by diospyrin and its ethanolamine derivative.
    Mukherjee P; Majee SB; Ghosh S; Hazra B
    Int J Antimicrob Agents; 2009 Dec; 34(6):596-601. PubMed ID: 19783125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.
    Zhang C; Qu Y; Niu B
    Bioorg Med Chem; 2016 Nov; 24(22):5781-5786. PubMed ID: 27667553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
    Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
    Walker J; Saravia NG
    J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
    Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
    Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo.
    Saha S; Mukherjee T; Chowdhury S; Mishra A; Chowdhury SR; Jaisankar P; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2013 Dec; 86(12):1673-87. PubMed ID: 24134912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
    Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of Leishmania donovani.
    Hazra S; Ghosh S; Das Sarma M; Sharma S; Das M; Saudagar P; Prajapati VK; Dubey VK; Sundar S; Hazra B
    Exp Parasitol; 2013 Oct; 135(2):407-13. PubMed ID: 23973194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy.
    Chowdhury AR; Mandal S; Goswami A; Ghosh M; Mandal L; Chakraborty D; Ganguly A; Tripathi G; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
    Mol Med; 2003; 9(1-2):26-36. PubMed ID: 12765337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
    Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
    Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.